MET Price Prediction Next Week
Technical Analysis
MetLife's stock shows a strong upward trend with a 25.3% gain over the past year, outperforming the S&P 500's 20.6% return. The recent price action indicates a consolidation phase following Q4 earnings release.
News Sentiment & Event Impact
- Recent Q4 earnings showed mixed results with adjusted EPS of $2.08, up 7.8% YoY but below estimates
- Stock experienced a 1.6% decline post-earnings due to:
- Lower non-medical health underwriting margins
- Declining earnings in Retirement and Income Solutions segment
- Positive note: Adjusted operating revenues increased 5.4% to $19.7B
Analyst Consensus
Strong analyst support with:
- 12 Strong Buy ratings
- 2 Moderate Buy ratings
- 4 Hold ratings
- Mean price target: $96.50 (15% upside potential)
- Highest target: $110 (31.1% upside)
Price Prediction for Next Week Based on technical indicators and news sentiment:
- Support level: $82.50
- Resistance level: $85.00
- Target price: $84.20
Trading Recommendation: BUY Rationale:
- Strong analyst consensus
- Positive revenue growth
- Technical indicators showing upward momentum
- EPS expected to grow 19% YoY in 2025
- Defensive stock characteristics beneficial in current trade war environment
MET Similar Chart Price Prediction
The price of MET is predicted to go up -6.44%, based on the high correlation periods with SPNS. The similarity of these two price pattern on the periods is 96.67%.
MET
SPNS
Down: -6.44%Similarity: 96.67%
MET Revenue Forecast
MET EPS Forecast
MET FAQs
What is MET revenue forecast for next quarter？
What is MET eps forecast for next quarter？
MET VS S&P500
MetLife's leading market positions in various international markets (particularly Asia and Latin America) provide opportunities for growth.
MetLife's strategy has reduced exposure to riskier products like variable annuities with minimum guarantees and has increased investments in segments with steadier cash flows like the group benefits business.
The company will be a net beneficiary of rising interest rates in the long run as it can reinvest its maturing fixed-income securities at a higher yield.
MET Analyst's Forecast
Elyse Greenspan
Wells Fargo
Buy
2025-02-19
Price Target
$92 → $97
Upside
+16.77%
Wells Fargo raised the firm's price target on MetLife to $97 from $92 and keeps an Overweight rating on the shares. The firm updated estimates in the life insurance group post the Q4 reports. Wells left the Q4 earnings favoring the more defensive names within the life sector. Its top life idea is Unum Group (UNM).
Ryan Krueger
Keefe, Bruyette & Woods
Buy
2025-02-12
Price Target
$100 → $98
Upside
+18.46%
Jack Matten
BMO Capital
Hold
2025-01-23
Price Target
$97
Upside
+11.8%
